Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Rescue of primary immunosuppressant Rx following liver, lung, heart, pancreas, and limb transplant.
Approximate number of candidates: 3000 awaiting liver transplant and 9000 awaiting kidney transplant in USA; 15,000 living liver transplant and 50,000 kidney transplant recipients are chronically receiving immunosuppressants.
Has been used to suppress the inflammation associated with ulcerative colitis.
Htn: CCBs may be effective in treating tacrolimus-associated Htn, but care is required. Interference with tacrolimus metabolism may necessitate a reduction in dose.
Nephrotoxicity: Do not administer concurrently with cyclosporine; administer cautiously with other potentially nephrotoxic drugs (e.g., aminoglycoside antibiotics).
Hypersensitivity may occur with IV formulation; pts should be monitored for 30 min after injection.
May result in opioid-induced hyperalgesia.
Drug is metabolized by cytochrome P450 (3A) enzyme system. Other medications that inhibit or induce this enzyme may affect tacrolimus drug levels.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here